Additionally, it is important to investigate whether interventions aimed at reducing fat mass, such as diet and exercise programs or medications like aromatase inhibitors, can effectively lower the risk of breast cancer in postmenopausal women. The gene discussed is CYP19A1; the disease is breast carcinoma.